Search

UT Southwestern offers every treatment option for patients with head and neck cancer, such as TORS, radiosurgery using CyberKnife, and immunotherapy.

Through clinical trials, UT Southwestern offers access to many of the latest head and neck cancer treatments, such as immunotherapy and robotic surgery.

At UT Southwestern, our support services for head and neck cancer focus on rehabilitation, psychology, and survivorship to help patients.

CHEK2 P/LP variants are inherited in an autosomal dominant fashion. People with CHEK2 have an increased risk of developing breast and prostate cancer.

Familial Adenomatous Polyposis (FAP) is a very rare condition that accounts for about 1% of new cases of colorectal cancer. People with FAP typically develop hundreds to thousands of polyps (adenomas) in their colon and rectum by age 30-40. FAP is caused by mutations in the adenomatous polyposis coli (APC) gene.

UT Southwestern is experienced in providing care for people with hereditary paraganglioma-pheochromocytoma syndrome.

UT Southwestern is home to one of the largest hereditary cancer programs in the country, providing expert care for individuals with Li-Fraumeni syndrome.

Lynch syndrome is an inherited cancer risk condition that increases a person’s chances of developing multiple types of cancer. It is caused by mutations, or breaks, of the MLH1, MSH2, MSH6, PMS2, or EPCAM genes.

UT Southwestern is home to one of the largest hereditary cancer programs in the country, providing expert care for individuals with PALB2 P/LP variants.

UT Southwestern is a PTEN Clinical Center of Excellence, which means our team has outstanding expertise in handling the health care needs of individuals with PHTS.